ArticleThe British journal of radiology2022

Tumour growth rates of prostate cancer during active surveillance: is there a difference between MRI-visible low and intermediate-risk disease?

Francesco Giganti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.